Market Cap
$91.9B
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | Morgan Stanley | MAINTAIN | Overweight | 55% |
| Jul 31, 2026 | UBS | MAINTAIN | Buy | 55% |
| Jul 31, 2026 | Bernstein | MAINTAIN | Outperform | 51% |
| Jul 7, 2026 | Wolfe Research | INITIATE | Outperform | 52% |
| Jul 2, 2026 | UBS | MAINTAIN | Buy | 55% |
| Jun 15, 2026 | Morgan Stanley | UPGRADE | Overweight | 55% |
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 6 | 15 | 6 | 0 | 0 | 78% | |
| Aug 1, 2026 | 7 | 14 | 4 | 1 | 0 | 81% | |
| Jul 1, 2026 | 7 | 14 | 4 | 1 | 0 | 81% | |
| Jun 1, 2026 | 7 | 11 | 6 | 1 | 0 | 72% | |
| May 1, 2026 | 7 | 11 | 7 | 2 | 0 | 67% | |
| Apr 1, 2026 | 7 | 11 | 7 | 2 | 0 | 67% | |
| Mar 1, 2026 | 6 | 11 | 8 | 2 | 0 | 63% | |
| Feb 1, 2026 | 6 | 11 | 8 | 1 | 1 | 63% |
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $2.34 | $2.24–$2.48 | 9.5% | -2.2% | 1↑ 0↓ | $1.9B | 3 |
| Next Q | $2.52 | $2.49–$2.55 | 17.7% | +1.2% | 1↑ 0↓ | $2.0B | 2 |
| Current FY | $9.88 | $9.63–$10.14 | 10.2% | +0.1% | 7↑ 2↓ | $7.6B | 9 |
| Next FY | $11.05 | $10.27–$11.31 | 11.9% | +0.9% | 7↑ 4↓ | $8.3B | 9 |
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $2.344 | — |
| 7d ago | $2.396 | -0.052 |
| 30d ago | $2.396 | -0.052 |
| 60d ago | $2.396 | -0.052 |
| 90d ago | $2.423 | -0.079 |